Riskpilot← Back to searchSign inGet full accessNÆVRALØKKA AS
ASActiveOrg 989286455Verksveien 19, 3330 SkotselvUtvikling og salg av egen fast eiendom ellers · NACE 41109Est. 20060 employees
Revenue 2022
NOK 0
EBITDA margin
—
-76% vs 2021
Equity ratio
85.8%
Financial strength
Net profit 2022
NOK 8K
+154% vs 2021
| Revenue | NOK 0 | — |
| EBITDA | NOK -26K | -76% |
| Net profit | NOK 8K | +154% |
| Total assets | NOK 602K | +31% |
| Equity | NOK 517K | +29% |
| Employees | 0 | — |
Legal name
NÆVRALØKKA AS
Org number
989286455
Legal form
Aksjeselskap
NACE code
41109 · Utvikling og salg av egen fast eiendom ellers
Founded
18. februar 2006
Share capital
NOK 50 000 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2022-12-31
Financial year
January – December
Signatory rights
Øystein magnus berg
Company purpose
Eiendomsutvikling og sentrumsutvikling, samt deltakelse i annen virksomhet.
Address
Verksveien 19, 3330 Skotselv
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9 | 97 | 0 | 0 |
| Staff expenses | −60 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −104 | −114 | −60 | −26 | −26 | −38 | −21 | −14 | −5 | −4 | −23 | −43 | 88 | −15 | −26 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | −104 | −114 | −60 | −26 | −26 | −38 | −21 | −14 | −5 | −4 | −23 | −43 | 88 | −15 | −26 |
| Net financials | 0 | −21 | −20 | −3 | −7 | −9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | −104 | −134 | −80 | −37 | −33 | −47 | −21 | −14 | −5 | −4 | −23 | −43 | 88 | −15 | −26 |
| Tax | −0 | −0 | 7 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −34 |
| Net profit | −104 | −134 | −87 | −37 | −33 | −47 | −21 | −14 | −5 | −4 | −23 | −43 | 88 | −15 | 8 |
| Item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 921 | 846 | 896 | 987 | 1 011 | 1 020 | 622 | 621 | 623 | 639 | 625 | 536 | 474 | 461 | 602 |
| Equity | 413 | 279 | 400 | 479 | 483 | 436 | 415 | 401 | 396 | 392 | 369 | 326 | 414 | 400 | 517 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 206 | 206 | 226 | 256 | 206 | 60 | 0 | 73 |
| Short-term debt | 508 | 567 | 496 | 508 | 528 | 583 | 206 | 13 | 20 | 20 | 0 | 3 | 0 | 61 | 12 |
| Total debt | 508 | 567 | 496 | 508 | 528 | 583 | 206 | 219 | 226 | 246 | 256 | 210 | 60 | 61 | 86 |
EBITDA margin
-2569200.0%
This company
15.8%
Market median
-16260859% vs market
20082022
Equity ratio
85.8%
This company
38.2%
Market median
+125% vs market
20082022
Return on equity
1.5%
This company
18.4%
Market median
-92% vs market
20082022
Net profit margin
794000.0%
This company
8.1%
Market median
+9802369% vs market
20082022
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20082022
Debt / equity
0.17×
This company
0.62×
Market median
+73% vs market
20082022
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
- Annual report 2011Filed via Brønnøysundsregistrene · Period 2011-01-01 – 2011-12-31
- Annual report 2010Filed via Brønnøysundsregistrene · Period 2010-01-01 – 2010-12-31
- Annual report 2009Filed via Brønnøysundsregistrene · Period 2009-01-01 – 2009-12-31
- Annual report 2008Filed via Brønnøysundsregistrene · Period 2008-01-01 – 2008-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
OT Chief Executive Officer | Chief Executive Officer | 2014 | — | — |
IL Deputy Member | Deputy Member | 2017 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2017 | — | — | |
| Chairman | 2022 | — | — | |
| Board of Directors | 2022 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of NÆVRALØKKA AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ole Thorud | Chief Executive Officer | 0 companies |
| Inger Lise Thorud | Deputy Member | 0 companies |
| Henning Thorud | Chairman | 0 companies |
| Øystein Magnus Berg | Chairman | 0 companies |
| Cecilia Ines Uchima Berg | Board of Directors | 0 companies |